Association and interaction of PPAR-complex gene variants with latent traits of left ventricular diastolic function

[1]  Judy H. Cho,et al.  Finding the missing heritability of complex diseases , 2009, Nature.

[2]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2009, Circulation.

[3]  B. Cohen,et al.  Genetic Interactions Between Transcription Factors Cause Natural Variation in Yeast , 2009, Science.

[4]  F. Flachskampf,et al.  Recommendations for the evaluation of left ventricular diastolic function by echocardiography. , 2008, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[5]  L. de las Fuentes,et al.  Enhanced detection of genetic association of hypertensive heart disease by analysis of latent phenotypes , 2008, Genetic epidemiology.

[6]  C. Carty,et al.  Cholesterol ester transfer protein, interleukin-8, peroxisome proliferator activator receptor alpha, and Toll-like receptor 4 genetic variations and risk of incident nonfatal myocardial infarction and ischemic stroke. , 2008, The American journal of cardiology.

[7]  B. C. Kwan,et al.  Peroxisome Proliferator-Activated Receptor-Gamma Gene Polymorphism and Risk of Cardiovascular Disease in Patients with Diabetic Nephropathy , 2008, American Journal of Nephrology.

[8]  X. Adiconis,et al.  PPARGC1A Variation Associated With DNA Damage, Diabetes, and Cardiovascular Diseases , 2008, Diabetes.

[9]  Yan Su.  Association study between PPARGC1A Thr394Thr/ Gly482Ser polymorphisms and type 2 diabetes: Association study between PPARGC1A Thr394Thr/ Gly482Ser polymorphisms and type 2 diabetes , 2008 .

[10]  N. Schork,et al.  Accommodating linkage disequilibrium in genetic-association analyses via ridge regression. , 2008, American journal of human genetics.

[11]  K. Furie,et al.  Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2007, Circulation.

[12]  J. Golledge,et al.  Relationship between two sequence variations in the gene for peroxisome proliferator-activated receptor-gamma and plasma homocysteine concentration. Health in men study , 2008, Human Genetics.

[13]  Li Yan,et al.  Association between peroxisome proliferator-activated receptor-gamma coactivator-1alpha gene polymorphisms and type 2 diabetes in southern Chinese population: role of altered interaction with myocyte enhancer factor 2C. , 2007, Chinese medical journal.

[14]  Zuyi Yuan,et al.  PPARgamma gene C161T substitution is associated with reduced risk of coronary artery disease and decreased proinflammatory cytokine expression. , 2007, American heart journal.

[15]  Corey L. Reynolds,et al.  Reversal of Systemic Hypertension-Associated Cardiac Remodeling in Chronic Pressure Overload Myocardium by Ciglitazone , 2007, International journal of biological sciences.

[16]  A. Bhat,et al.  Interaction between the UCP2–866G/A, mtDNA 10398G/A and PGC1α p.Thr394Thr and p.Gly482Ser polymorphisms in type 2 diabetes susceptibility in North Indian population , 2007, Human Genetics.

[17]  Ekta Rai,et al.  PGC-1α Thr394Thr and Gly482Ser variants are significantly associated with T2DM in two North Indian populations: a replicate case-control study , 2007, Human Genetics.

[18]  R. Gropler,et al.  Metabolic syndrome is associated with abnormal left ventricular diastolic function independent of left ventricular mass. , 2006, European heart journal.

[19]  Chun-yan Fu,et al.  Polymorphisms of the peroxisome proliferator-activated receptor-γ coactivator-1α gene are associated with hypertrophic cardiomyopathy and not with hypertension hypertrophy , 2007, Clinical chemistry and laboratory medicine.

[20]  A. Bhat,et al.  PGC-1alpha Thr394Thr and Gly482Ser variants are significantly associated with T2DM in two North Indian populations: a replicate case-control study. , 2007, Human genetics.

[21]  Chun-yan Fu,et al.  Polymorphisms of the peroxisome proliferator-activated receptor-gamma coactivator-1alpha gene are associated with hypertrophic cardiomyopathy and not with hypertension hypertrophy. , 2007, Clinical chemistry and laboratory medicine.

[22]  A. Bhat,et al.  Interaction between the UCP2–866G/A, mtDNA 10398G/A and PGC1α p.Thr394Thr and p.Gly482Ser polymorphisms in type 2 diabetes susceptibility in North Indian population , 2007, Human Genetics.

[23]  S. O’Rahilly,et al.  PPAR gamma and human metabolic disease. , 2006, The Journal of clinical investigation.

[24]  Serguei V. S. Pakhomov,et al.  Systolic and diastolic heart failure in the community. , 2006, JAMA.

[25]  H. Taegtmeyer,et al.  Association of plasma free fatty acids and left ventricular diastolic function in patients with clinically severe obesity. , 2006, The American journal of clinical nutrition.

[26]  V. Mohan,et al.  Effect of polymorphisms in the PPARGC1A gene on body fat in Asian Indians , 2006, International Journal of Obesity.

[27]  S. O’Rahilly,et al.  PPARγ and human metabolic disease , 2006 .

[28]  Wj Gauderman,et al.  QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies , 2006 .

[29]  Sun Woo Kim,et al.  Effects of two common polymorphisms of peroxisome proliferator-activated receptor-gamma gene on metabolic syndrome. , 2006, Archives of medical research.

[30]  L. Bierut,et al.  Endophenotypes Successfully Lead to Gene Identification: Results from the Collaborative Study on the Genetics of Alcoholism , 2006, Behavior genetics.

[31]  Frédérique Frouin,et al.  Optimization of factor analysis of the left ventricle in echocardiography for detecting wall motion abnormalities. , 2005, Ultrasound in medicine & biology.

[32]  V. Mohan,et al.  Peroxisome proliferator‐activated receptor‐γ co‐activator‐1α (PGC‐1α) gene polymorphisms and their relationship to Type 2 diabetes in Asian Indians , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[33]  I. Vauhkonen,et al.  Haplotypes of PPARGC1A are associated with glucose tolerance, body mass index and insulin sensitivity in offspring of patients with type 2 diabetes , 2005, Diabetologia.

[34]  Xianlin Han,et al.  Transgenic Expression of Fatty Acid Transport Protein 1 in the Heart Causes Lipotoxic Cardiomyopathy , 2005, Circulation research.

[35]  R. Devereux,et al.  Normalization for body size and population-attributable risk of left ventricular hypertrophy: the Strong Heart Study. , 2005, American journal of hypertension.

[36]  D. Atar,et al.  Echocardiographic indices of left ventricular diastolic dysfunction in 647 individuals with preserved left ventricular systolic function , 2004, European journal of heart failure.

[37]  I. Yamaguchi,et al.  Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with the nuclear factor-kappa-B pathway. , 2004, Journal of the American College of Cardiology.

[38]  J. Saffitz,et al.  Cardiac-Specific Induction of the Transcriptional Coactivator Peroxisome Proliferator-Activated Receptor &ggr; Coactivator-1&agr; Promotes Mitochondrial Biogenesis and Reversible Cardiomyopathy in a Developmental Stage-Dependent Manner , 2004, Circulation research.

[39]  E. Bollano,et al.  Cardiac lipid accumulation associated with diastolic dysfunction in obese mice. , 2003, Endocrinology.

[40]  N. Najimudin,et al.  Molecular characterisation of six alternatively spliced variants and a novel promoter in human peroxisome proliferator-activated receptor alpha. , 2003, Biochemical and biophysical research communications.

[41]  I. Gottesman,et al.  The endophenotype concept in psychiatry: etymology and strategic intentions. , 2003, The American journal of psychiatry.

[42]  D. Kelly.  PPARs of the heart: three is a crowd. , 2003, Circulation research.

[43]  J. Sanderson,et al.  Peak early diastolic mitral annulus velocity by tissue Doppler imaging adds independent and incremental prognostic value. , 2003, Journal of the American College of Cardiology.

[44]  Douglas W Mahoney,et al.  Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. , 2003, JAMA.

[45]  P. Herrero,et al.  Myocardial Fatty Acid Metabolism: Independent Predictor of Left Ventricular Mass in Hypertensive Heart Disease , 2003, Hypertension.

[46]  H. Taegtmeyer.  Switching Metabolic Genes to Build a Better Heart , 2002, Circulation.

[47]  P. Pibarot,et al.  Mitral annulus velocities by Doppler tissue imaging: practical implications with regard to preload alterations, sample position, and normal values. , 2002, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[48]  T. Kadowaki,et al.  A genetic variation in the PGC-1 gene could confer insulin resistance and susceptibility to Type II diabetes , 2002, Diabetologia.

[49]  D. Brutsaert,et al.  New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment. , 2002, Circulation.

[50]  C. Otto,et al.  Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. , 2002, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[51]  Xianlin Han,et al.  The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. , 2002, The Journal of clinical investigation.

[52]  H. Taegtmeyer,et al.  Reactivation of Peroxisome Proliferator-activated Receptor α Is Associated with Contractile Dysfunction in Hypertrophied Rat Heart* , 2001, The Journal of Biological Chemistry.

[53]  M. Fujita,et al.  Abnormal myocardial free fatty acid utilization deteriorates with morphological changes in the hypertensive heart. , 2001, Japanese circulation journal.

[54]  P. Herrero,et al.  A novel mouse model of lipotoxic cardiomyopathy. , 2001, The Journal of clinical investigation.

[55]  D. Kelly,et al.  PPAR signaling in the control of cardiac energy metabolism. , 2001, Trends in cardiovascular medicine.

[56]  S. Ommen,et al.  Clinical Utility of Doppler Echocardiography and Tissue Doppler Imaging in the Estimation of Left Ventricular Filling Pressures: A Comparative Simultaneous Doppler-Catheterization Study , 2000, Circulation.

[57]  J. Saffitz,et al.  Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. , 2000, The Journal of clinical investigation.

[58]  D. Kelly,et al.  Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth. , 2000, The Journal of clinical investigation.

[59]  Erkki Oja,et al.  Independent component analysis: algorithms and applications , 2000, Neural Networks.

[60]  Rick B. Vega,et al.  The Coactivator PGC-1 Cooperates with Peroxisome Proliferator-Activated Receptor α in Transcriptional Control of Nuclear Genes Encoding Mitochondrial Fatty Acid Oxidation Enzymes , 2000, Molecular and Cellular Biology.

[61]  L. Orci,et al.  Lipotoxic heart disease in obese rats: implications for human obesity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[62]  Xing-li Wang,et al.  Peroxisome proliferator-activated receptor γ C161→T polymorphism and coronary artery disease , 1999 .

[63]  X. L. Wang,et al.  Peroxisome proliferator-activated receptor gamma C161-->T polymorphism and coronary artery disease. , 1999, Cardiovascular research.

[64]  C. Newgard,et al.  Lipoapoptosis in beta-cells of obese prediabetic fa/fa rats. Role of serine palmitoyltransferase overexpression. , 1998, The Journal of biological chemistry.

[65]  H. Taegtmeyer,et al.  Regulation of Energy Metabolism of the Heart during Acute Increase in Heart Work* , 1998, The Journal of Biological Chemistry.

[66]  R. Unger,et al.  Fatty acid-induced β cell apoptosis: A link between obesity and diabetes , 1998 .

[67]  Thierry C. Gillebert,et al.  How to diagnose diastolic heart failure , 1998 .

[68]  R. Unger,et al.  Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[69]  How to diagnose diastolic heart failure. European Study Group on Diastolic Heart Failure. , 1998, European heart journal.

[70]  M. Quiñones,et al.  Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. , 1997, Journal of the American College of Cardiology.

[71]  B. Lorell,et al.  Failure to maintain a low ADP concentration impairs diastolic function in hypertrophied rat hearts. , 1997, Circulation.

[72]  S. Daniels,et al.  Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. , 1992, Journal of the American College of Cardiology.

[73]  N. Reichek,et al.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. , 1989, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[74]  R. Bing,et al.  Metabolism of the human heart. II. Studies on fat, ketone and amino acid metabolism. , 1954, The American journal of medicine.